Belite Bio, Inc (BLTE) Misses Q1 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q1 EPS of ($0.31), $0.05 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy